Madrigal Pharmaceuticals, Inc. (MDGL)
512.39
-6.35
(-1.22%)
USD |
NASDAQ |
Apr 24, 16:00
513.31
+0.92
(+0.18%)
After-Hours: 20:00
Madrigal Pharmaceuticals EPS Diluted (Quarterly) : -2.566 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.538 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Eli Lilly & Co. | 7.024 |
| PTC Therapeutics, Inc. | -1.673 |
| Protagonist Therapeutics, Inc. | -0.6932 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.58M |
| Revenue (Quarterly) | 321.08M |
| Total Expenses (Quarterly) | 379.66M |
| Enterprise Value | 11.11B |
| Gross Profit Margin (Quarterly) | 92.26% |
| Profit Margin (Quarterly) | -18.24% |
| Earnings Yield | -2.51% |
| Normalized Earnings Yield | -2.494 |